0001502523-13-000001.txt : 20130620 0001502523-13-000001.hdr.sgml : 20130620 20130620165723 ACCESSION NUMBER: 0001502523-13-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130620 DATE AS OF CHANGE: 20130620 EFFECTIVENESS DATE: 20130620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arch Therapeutics, Inc. CENTRAL INDEX KEY: 0001502523 IRS NUMBER: 204425710 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-198360 FILM NUMBER: 13924958 BUSINESS ADDRESS: STREET 1: 1 CHIEFTAIN LANE CITY: NATICK STATE: MA ZIP: 01760 BUSINESS PHONE: 617-395-1397 MAIL ADDRESS: STREET 1: 1 CHIEFTAIN LANE CITY: NATICK STATE: MA ZIP: 01760 D 1 primary_doc.xml X0706 D LIVE 0001502523 Arch Therapeutics, Inc. 1 CHIEFTAIN LANE NATICK MA MASSACHUSETTS 01760 617-395-1397 MASSACHUSETTS None None Corporation true TERRENCE W. NORCHI ONE CHIEFTAIN LANE NATICK MA MASSACHUSETTS 01760 Executive Officer Director AVTAR DHILLON ONE CHIEFTAIN LANE NATICK MA MASSACHUSETTS 01760 Director ARTHUR ROSENTHAL ONE CHIEFTAIN LANE NATICK MA MASSACHUSETTS 01760 Director Biotechnology Decline to Disclose 06 false 2013-06-19 false true true false 0 370397 370397 0 false 16 0 0 0 true The proceeds from the offering will be used for general working capital purposes including the payment of payroll. The officers listed in Item 3 will be among the employees whose salary or other compensation may be paid from a portion of such proceeds. false Arch Therapeutics, Inc. /s/ Terrence W. Norchi Terrence W. Norchi President & CEO 2013-06-19